loading   Loading page...

Välkommen hit.
Om du ser denna ruta är detta projekt arkiverat.
Varmt välkommen över till våra aktiva sidor.


Cancer Crosslinks 2015
Lund - Sweden


Welcome to the 3rd Cancer Crosslink Sweden

October 14, 2015, at Medicon Village, Lund

By bringing together researchers from healthcare providers, academia, and industry with representatives from regulatory units in a one-day meeting, we want to start an interdisciplinary discussion that could lead to new partnerships to develop the area of ​​Personalized Medicine.
The theme of this year Cancer Crosslinks will be on Personalized Medicine and Immuno-oncology with a clinical focus.


The concept of Cancer Crosslink meetings was established in Oslo, Norway, eight years ago when Oslo Cancer Cluster www.oslocancercluster.no in collaboration with Bristol-Myers Squibb arranged the first Cancer Crosslink meeting.
Since then, initiatives to Crosslink meetings has been taken both in Sweden and Finland.


In collaboration with


The meeting provides great opportunities for networking, with several breaks where coffee, lunch and dinner
will be served free of charge.

  • Session I: Personalized Medicine – A clinical Challenge
  • Session II: Immunooncology – Clinical experiences
  • Session III: Linking research to clinic Panel discussion: From research to the benefit of the patient - how to make this time shorter
  • Download presentations from the sessions
Confirmed Speakers
Per Norlén Alligator Bioscience AB Sweden
Douglas Hanahan Swiss Institute for Experimental Cancer Research USA
Minna Tanner Department of Oncology, Tampere University Hospital Finland
Håkan Mellstedt Department of Oncology-Pathology, Karolinska Institute Sweden
Kristian Pietras Division of Translational Cancer Research, Lund University Sweden
Lana Kadalaft Department of Obstetrics and Gynecology, University of Pennsylvania USA
Jon Retzlaff Managing Director of Science Policy & Government Affairs, American Association for Cancer Research (AACR) USA
Priti Hegde Genentech Inc. USA
Jong-Seo Lee AbClon Inc. Republic of Korea
Holger Gerhardt Integrative Vascular Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC) Germany



Practical information

The conference will take place at the Medicon Village

Address: Sheelevägen 2, Lund

Map and transport/parking information, Medicon Village:

Click here to open PDF with transport and parking information.


For more information, please contact Kristina Lundberg:

+46 46 2229638 /+46 2223859

For information about Lund city and
book your accomodation:


The hotel closest to the conference is Hotel Elite Ideon.

Medicon Weekend is an inspirational meeting organized back to back with Cancer Crosslink at Medicon Village on 15-16th of October. Four different health topics will be discussed at Medicon Weekend and the first one is cancer. For more information, please visit: http://www.mediconweekend.se/
As a participant at Cancer Crosslinks 2015, you now have the opportunity to receive a free ticket to Medicon Weekend. The first ten Cancer Crosslinks participants emailing to Misa.Diestel@mediconvillage.se will receive a free ticket!


At Medicon Village the entire value chain, from researchers to innovators and businessmen, will work together under a single flag to create value for people’s health and wellbeing.
Different skills and knowledge brought together through collaboration create growth, and good ideas that are born out of everyday meetings can make the difference for tomorrow’s patients. 


Lund is located in the southern part of Sweden, also known as the County of Skåne. It is a vibrant research area hosting one of the oldest and the largest university in Scandinavia - Lund University.
The region consist of an internationally renowned life science cluster Medicon Valley with more than 350 Research and Development companies in the fields of biotechnology, pharmaceuticals and medical technology.
The collaboration between the academy, the hospitals and the industry has fostered innovative and dynamic research projects in the fields of cancer, diabetes, inflammation and CNS among others.


CREATE Health:

CREATE Health is a Strategic Centre for Translational Cancer Research at Lund University (www.createhealth.lth.se).
By integrating clinicians and researchers from Lund University Hospital with researchers from the Faculties of Medicine, Natural Sciences and Engineering, using a superbly equipped and integrated “omics” platforms, concentrated in a single area, a centre unique in its kind has been created.
The vision of CREATE Health is to use an integrative approach to develop novel diagnostics and therapeutics, based on identified markers and molecular signatures and to create a substantial social impact for the patient, through direct application of research for selection of an optimal, individually-based, cancer treatment, i.e. personalized medicine.